Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups

B. Durupınar; A. Saniç; M. Günaydın; M. Piirinçciler

doi:10.5835/jecm.v9i3-4.434

Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups

Year 1992, Volume: 9 Issue: 3-4, - , 22.12.2009

B. Durupınar A. Saniç M. Günaydın M. Piirinçciler

Abstract

The hepatitis C Virus (HCV) is now known to be the chief cause of transfusion-associated non-A non-B hepatitis (NANBH). The prevalence of HCV infection was as-sessed by means of Abbott enzyme-linked immunosorbent assay for serum anti-HCV antibodies. 2222 serum samples were selected from different patient groups, accor¬ding to their risk of blood-borne viral infections. Anti-HCV antibodies were detected in 25 of 83 (30.12%) risk group (Haemodialysis patients and polytransfused patients with haemophilia, thalassemia, patients of cardiac surgery). Among healtyh subjects, wit¬hout risk factors for hepatitis, the overall prevalance of Anti-HCV was (0.14%).

Hepatit C virusu (HCV), transfüzyon ile ilişkili non-A, non-B hepatiti (NANBH)'nin başlıca nedenidir. HCV infeksiyon prevalansı Abbott'un anti-HCV antikorları için enzy-me-linked immunosorbent assay (ELISA) test kiti kullanılarak saptanmıştır. 2222 serum örneği, kan yoluyla viral infeksiyon bulaşma riski olan değişik hasta gruplarından toplanmıştır. Anti-HCV antikorları 83 risk grubunun (hemodiyaliz hastası, he¬mofili, thalassemi gibi politransfüze hastalar ve kalp cerrahisi hastaları) 25 (%30.12)'inde saptanmıştır. Hepatit risk faktörü bulunmayan sağlıklı bireylerde anti-HCV prevalansı ise %0.14 olarak saptanmıştır.

Keywords

-

Year 1992, Volume: 9 Issue: 3-4, - , 22.12.2009

B. Durupınar A. Saniç M. Günaydın M. Piirinçciler

Abstract

There are 0 citations in total.

Details

Primary Language	English
Journal Section	Basic Medical Sciences
Authors	B. Durupınar This is me A. Saniç This is me M. Günaydın This is me M. Piirinçciler This is me
Publication Date	December 22, 2009
Submission Date	November 24, 2009
Published in Issue	Year 1992 Volume: 9 Issue: 3-4

Cite

APA	Durupınar, B., Saniç, A., Günaydın, M., Piirinçciler, M. (2009). Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups. Journal of Experimental and Clinical Medicine, 9(3-4). https://doi.org/10.5835/jecm.v9i3-4.434
AMA	Durupınar B, Saniç A, Günaydın M, Piirinçciler M. Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups. J. Exp. Clin. Med. December 2009;9(3-4). doi:10.5835/jecm.v9i3-4.434
Chicago	Durupınar, B., A. Saniç, M. Günaydın, and M. Piirinçciler. “Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups”. Journal of Experimental and Clinical Medicine 9, no. 3-4 (December 2009). https://doi.org/10.5835/jecm.v9i3-4.434.
EndNote	Durupınar B, Saniç A, Günaydın M, Piirinçciler M (December 1, 2009) Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups. Journal of Experimental and Clinical Medicine 9 3-4
IEEE	B. Durupınar, A. Saniç, M. Günaydın, and M. Piirinçciler, “Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups”, J. Exp. Clin. Med., vol. 9, no. 3-4, 2009, doi: 10.5835/jecm.v9i3-4.434.
ISNAD	Durupınar, B. et al. “Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups”. Journal of Experimental and Clinical Medicine 9/3-4 (December 2009). https://doi.org/10.5835/jecm.v9i3-4.434.
JAMA	Durupınar B, Saniç A, Günaydın M, Piirinçciler M. Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups. J. Exp. Clin. Med. 2009;9. doi:10.5835/jecm.v9i3-4.434.
MLA	Durupınar, B. et al. “Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups”. Journal of Experimental and Clinical Medicine, vol. 9, no. 3-4, 2009, doi:10.5835/jecm.v9i3-4.434.
Vancouver	Durupınar B, Saniç A, Günaydın M, Piirinçciler M. Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups. J. Exp. Clin. Med. 2009;9(3-4).